Tenon Medical, INC 8-K filings

Tenon Medical, Inc. has received a notice from Nasdaq for not meeting the minimum stockholders' equity requirement for continued listing.

Tenon Medical successfully held its 2024 Annual Stockholders Meeting, electing all director nominees and approving several key proposals including amendments to the equity incentive plan and ratification of the independent auditor.

Tenon Medical's Executive Vice President, Finance and Administration, Chief Financial Officer, and Assistant Secretary, Steven Van Dick, has announced his retirement, effective July 31, 2024.

Tenon Medical, Inc. has received a notice from Nasdaq stating that its common stock has failed to maintain the minimum bid price of $1.00 per share, potentially leading to delisting.

Tenon Medical has appointed Kristine Jacques, a seasoned medical device executive, to its Board of Directors, effective March 25, 2024.

Tenon Medical saw a significant increase in revenue and surgical procedures in 2023, with a 324% year-over-year revenue increase for the full year.

Tenon Medical, Inc. has successfully raised approximately $2.6 million in gross proceeds through a private placement of Series A Preferred Stock and retired $1.25 million in secured debt.

Tenon Medical stockholders approved an amendment to the company's charter, granting the board of directors the authority to issue preferred stock.

Tenon Medical has received a notice from Nasdaq for not meeting the minimum requirements for independent directors on its board and key committees after a director's resignation.